[1] Maniotis AJ,Folberg R,Hess A,et al.Vascular channel formation by human melanoma cells in vivo and in vitro:vasculogenic mimicry[J].Am J Pathol,1999,155(3):739-752. [2] Shirakawa K,Wakasugi H,Heike Y,et al.Vasculogenic mimicry and pseudo-comedo formation in breast cancer[J].Int J Cancer,2002,99(6):821-828. [3] Cai Xuansong,Jia Yongwei,Mei Jiong,et al.Tumor blood vessels formation in osteosarcoma:vasculogenesis mimicry[J].Chin J Med,2004,117(1):94-98. [4] 赵秀兰,杜静,张诗武,等.肝细胞癌中血管生成拟态的研究[J].中华肝脏病杂志,2006,14(1):41-44. [5] 范跃祖,孙伟,张文忠,等.原发性胆囊癌患者肿瘤血管生成拟态及其临床意义[J].中华医学杂志,2007,87(3):145-149. [6] Herbst RS,Yano S,Kuniyasu H,et al .Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma[J].Clin Cancer Res,2000,6(3):790-797. [7] Hess AR,Postovit LM,Margaryan NV,et al.Focal adhesion kinase promotes the aggressive melanoma phenotype[J].Cancer Res,2005,65(21):9851-9860. [8] Hendrix MJ,Seftor EA,Meltzer PS,et al.Expression and functional significance of VE-cadherin in aggressive human melanoma cells:role in vasculogenic mimicry[J].Proc Natl Acad Sci,2001,98(14):8018-8023. [9] Hess AR,Seftor EA,Gardner LM,et al.Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation:role of epithelial cell kinase (Eck/EphA2)[J].Cancer Res,2001,61(8):3250-3255. [10] Hess AR,Seftor EA,Seftor RE,et al.Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry[J].Cancer Res,2003,63(16):4757-4762. [11] Sood AK,Fletcher MS,Coffin JE,et al.Functional role of matrix metalloproteinases in ovarian tumor cell plasticity[J].Am J Obstet Gynecol,2004,190(4):899-909. [12] Seftor RE,Seftor EA,Kirschmann DA,et al.Targeting the tumor microenvironment with chemically modified tetracyclines:inhibition of laminin 5 gamma 2 chain promigratory fragments and vasculogenic mimicry[J].Mol Cancer Ther,2002,1(13):1173-1179. [13] Seftor RE,Seftor EA,Koshikawa N,et al.Cooperative interactions of laminin 5 gamma 2 chain,matrix metalloproteinase-2,and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma[J].Cancer Res,2001,61(17):6322-6327. [14] Ruf W,Seftor EA,Petrovan RJ,et al.Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry[J].Cancer Res,2003,63(17):5381-5389. |